93 related articles for article (PubMed ID: 3196414)
1. Intrinsic drug resistance in a human lung carcinoma xenograft is associated with overexpression of multidrug-resistance DNA-sequences and of plasma membrane glycoproteins.
Volm M; Bak M; Mattern J
Arzneimittelforschung; 1988 Aug; 38(8):1189-93. PubMed ID: 3196414
[TBL] [Abstract][Full Text] [Related]
2. Intrinsic and acquired multidrug resistance in human lung carcinomas grown in nude mice.
Mattern J; Bak M; Volm M
Anticancer Res; 1990; 10(1):177-80. PubMed ID: 1970715
[TBL] [Abstract][Full Text] [Related]
3. Acquired drug resistance in human lung carcinoma xenografts.
Volm M; Efferth T; Mattern J
Arzneimittelforschung; 1989 Aug; 39(8):828-31. PubMed ID: 2818670
[TBL] [Abstract][Full Text] [Related]
4. Induced multidrug-resistance in murine sarcoma 180 cells grown in vitro and in vivo and associated changes in expression of multidrug-resistance DNA-sequences and membrane glycoproteins.
Volm M; Bak M; Efferth T; Mattern J
Anticancer Res; 1988; 8(6):1169-78. PubMed ID: 3218953
[TBL] [Abstract][Full Text] [Related]
5. Immunocytochemical detection of a resistance-associated glycoprotein in tissue culture cells, ascites tumors and human tumor xenografts by Mab 265/F4.
Volm M; Bak M; Efferth T; Lathan B; Mattern J
Anticancer Res; 1988; 8(4):531-5. PubMed ID: 2902821
[TBL] [Abstract][Full Text] [Related]
6. Reversal of Vinca alkaloid resistance by anti-P-glycoprotein monoclonal antibody HYB-241 in a human tumor xenograft.
Rittmann-Grauer LS; Yong MA; Sanders V; Mackensen DG
Cancer Res; 1992 Apr; 52(7):1810-6. PubMed ID: 1348013
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of the multidrug resistance-associated protein (MRP) gene in vincristine but not doxorubicin-selected multidrug-resistant murine erythroleukemia cells.
Slapak CA; Fracasso PM; Martell RL; Toppmeyer DL; Lecerf JM; Levy SB
Cancer Res; 1994 Nov; 54(21):5607-13. PubMed ID: 7923205
[TBL] [Abstract][Full Text] [Related]
8. Radiosensitivity of drug-resistant human tumour xenografts.
Mattern J; Bak M; Hoever KH; Volm M
Strahlenther Onkol; 1989 Dec; 165(12):870-2. PubMed ID: 2603122
[TBL] [Abstract][Full Text] [Related]
9. Occurrence of a multidrug-resistant phenotype in human lung xenografts.
Mattern J; Bak M; Volm M
Br J Cancer; 1987 Oct; 56(4):407-11. PubMed ID: 3689658
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of P-glycoprotein in human lung carcinoma xenografts after fractionated irradiation in vivo.
Mattern J; Efferth T; Volm M
Radiat Res; 1991 Sep; 127(3):335-8. PubMed ID: 1679564
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G
Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476
[TBL] [Abstract][Full Text] [Related]
12. Intrinsic multidrug resistance in human lung carcinomas grown in nude mice.
Volm M; Bak M; Mattern J
Strahlenther Onkol; 1989 Jul; 165(7):524-6. PubMed ID: 2749490
[No Abstract] [Full Text] [Related]
13. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.
Hamaguchi K; Godwin AK; Yakushiji M; O'Dwyer PJ; Ozols RF; Hamilton TC
Cancer Res; 1993 Nov; 53(21):5225-32. PubMed ID: 8106143
[TBL] [Abstract][Full Text] [Related]
14. Advantage of in vivo chemosensitivity assay to detect vincristine-resistance in a human epidermoid carcinoma xenograft.
Abe Y; Yamazaki H; Oshika Y; Suto R; Tsugu A; Ota E; Satoh H; Ohnishi Y; Yanagawa T; Ueyama Y; Tamaoki N; Nakamura M
Anticancer Res; 1996; 16(2):729-34. PubMed ID: 8687121
[TBL] [Abstract][Full Text] [Related]
15. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
Nemati F; Livartowski A; De Cremoux P; Bourgeois Y; Arvelo F; Pouillart P; Poupon MF
Clin Cancer Res; 2000 May; 6(5):2075-86. PubMed ID: 10815935
[TBL] [Abstract][Full Text] [Related]
16. Cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma.
Kumar A; Soprano DR; Parekh HK
Cancer Res; 2001 Oct; 61(20):7552-5. PubMed ID: 11606393
[TBL] [Abstract][Full Text] [Related]
17. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
18. Development of drug resistance in a human epidermoid lung carcinoma xenograft line.
Mattern J; Bak M; Hoever KH; Volm M
Br J Cancer; 1988 Jul; 58(1):30-3. PubMed ID: 3166890
[TBL] [Abstract][Full Text] [Related]
19. Lack of influence of c-Ha-ras expression on the drug sensitivity of human bladder cancer histocultured in three-dimensions.
Theodorescu D; Connors KM; Groce A; Hoffman RM; Kerbel RS
Anticancer Res; 1993; 13(4):941-6. PubMed ID: 8352563
[TBL] [Abstract][Full Text] [Related]
20. Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models.
Peer D; Dekel Y; Melikhov D; Margalit R
Cancer Res; 2004 Oct; 64(20):7562-9. PubMed ID: 15492283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
